COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 119: Articles 1181-1190  | Next

The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic mice
Wu, X.-J., Oppelt, K. A., Fan, M., Marie, M. A., Swyers, M. M., Williams, A. J., Lemasson, I. M., Roper, R. L., Bolin, P., Yang, L. V.
10.1101/2024.12.26.630404 — Posted: 2024-12-27
Induction of an early IFN-γ cellular response and high plasma levels of SDF-1α are inversely associated with COVID-19 severity and residence in rural areas in Kenyan patients
Wanjiku, p. N., Orindi, B., Kimotho, J., Sayed, S., Shah, R., Saleh, M., Mwacharo, J., Maronga, C., Olouch, V., Karanu, A., Shah, J., Nneka, Z., Ochola-Oyier, L. I., Abdi, A. I., Dunachie, S., Bejon, P., Nduati, E., Ndungu, F. M.
10.1101/2024.12.22.24319505 — Posted: 2024-12-26
COVID-19 Beliefs, Behaviors, and Perceptions Among Students on a College Campus During the Global Coronavirus Pandemic
White, A., Iverson, G., Wright, L., Fallon, J. T., Humphrey, C.
10.1101/2024.12.23.24319584 — Posted: 2024-12-26
Monitoring COVID-19 Occurrence in a Resource-limited Setting - COVID-19 Sentinel Surveillance in Malawi
Ulaya, G., Kabaghe, A., Saussier, C., MacLachlan, E., Smith-Sreen, J., Katumbi, C., Bello, G., Tafatatha, T., Chaponda, L., Mvula, B., Kagoli, M., Chilima, B., Bitilinyu-Bangoh, J., Chisuwo, L., Babaye, Y., Chitenje, M., Bighignoli, B., Bangara, F., Namakhoma, I., Chauma-Mwale, A., OMalley, G., Mirkovic, K., Wadonda-Kabondo, N.
10.1101/2024.12.23.24319583 — Posted: 2024-12-26
Modelling the synergy between single-occupancy and PPE in controlling COVID-19 outbreaks on hospital wards
Zachreson, C., Schofield, R., Marshall, C., Kainer, M., Buising, K., Monty, J., Sullivan, S., Subbarao, K., Geard, N.
10.1101/2024.12.23.24319413 — Posted: 2024-12-26
IL-1β-driven NF-κB transcription of ACE2 as a Mechanism of Macrophage Infection by SARS-CoV-2
Lee, C., Khan, R., Mantsounga, C. S., Sharma, S., Pierce, J., Amelotte, E., Butler, C. A., Farinha, A., Parry, C., Caballero, O., Morrison, J. A., Uppuluri, S., Whyte, J. J., Kennedy, J. L., Zhang, X., Choudhary, G., Olson, R. M., Morrison, A. R.
10.1101/2024.12.24.630260 — Posted: 2024-12-26
mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice
Lee, D. W., Nasir, A., Elbashir, S., Jani, H., Speidel, T., Gorrie, A., Montes Berrueta, D., Martin, P., Tan, S., Hou, Y. J., Hardcastle, K., Edwards, D., Wu, K., Carfi, A., Budigi, Y.
10.1101/2024.12.24.629478 — Posted: 2024-12-26
Self-Perceived Decline in Memory and Concentration 9 and 12 months post COVID-19 infection
Ruivinho, C., Moniz, M., Goes, A. R., Soares, P., Leite, A., LOCUS group
10.1101/2024.12.19.24319396 — Posted: 2024-12-24
Post-COVID sequelae in people with multiple sclerosis and related disorders: a multicenter cross-sectional study
Hu, C., Song, J., McAlpine, L., Bar-Or, A., Dahl, M., Ferreira Brito, S., Kavak, K., Onomichi, K., Perrone, C., Riley, C., Song, E., Walker, E., Weinstock-Guttman, B., De Jager, P., Longbrake, E., Xia, Z.
10.1101/2024.12.20.24319365 — Posted: 2024-12-24
Characterizing postoperative T and B cell dysfunction in cancer surgery patients, using COVID-19 as a model antigen
Olanubi, O., MacDonald, R., Dion, T., Alam, R., De Souza, C. T., Hu, R., Crawley, A. M., Auer, R. C.
10.1101/2024.12.23.629453 — Posted: 2024-12-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).